Literature DB >> 12359416

Dialysis-free survival after surgical repair of ischemic nephropathy.

Kimberley J Hansen1, Gregory S Cherr, Richard H Dean.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12359416     DOI: 10.1016/s0967-2109(02)00040-6

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


× No keyword cloud information.
  6 in total

Review 1.  Renal artery stenosis: optimizing diagnosis and treatment.

Authors:  William R Colyer; Ehab Eltahawy; Christopher J Cooper
Journal:  Prog Cardiovasc Dis       Date:  2011 Jul-Aug       Impact factor: 8.194

2.  Adjunctive mesenchymal stem/stromal cells augment microvascular function in poststenotic kidneys treated with low-energy shockwave therapy.

Authors:  Xiao-Jun Chen; Xin Zhang; Kai Jiang; James D Krier; Xiangyang Zhu; Sabena Conley; Amir Lerman; Lilach O Lerman
Journal:  J Cell Physiol       Date:  2020-05-19       Impact factor: 6.384

3.  Diastolic function predicts survival after renal revascularization.

Authors:  Racheed J Ghanami; Hamza Rana; Timothy E Craven; John Hoyle; Matthew S Edwards; Kimberley J Hansen
Journal:  J Vasc Surg       Date:  2011-08-06       Impact factor: 4.268

4.  Early atherosclerosis aggravates the effect of renal artery stenosis on the swine kidney.

Authors:  Victor H Urbieta-Caceres; Ronit Lavi; Xiang-Yang Zhu; John A Crane; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

5.  Improved renal outcomes after revascularization of the stenotic renal artery in pigs by prior treatment with low-energy extracorporeal shockwave therapy.

Authors:  Xiao-Jun Chen; Xin Zhang; Kai Jiang; James D Krier; Xiangyang Zhu; Amir Lerman; Lilach O Lerman
Journal:  J Hypertens       Date:  2019-10       Impact factor: 4.844

Review 6.  Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL).

Authors:  Sandra M S Herrmann; Ahmed Saad; Stephen C Textor
Journal:  Nephrol Dial Transplant       Date:  2014-04-09       Impact factor: 5.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.